Reduced risk of CIN2+ recurrence in women immunized with a 9-valent HPV vaccine post-excision: Retrospective cohort study

References

• Petráš M, Dvořák V, Lomozová D, Máčalík R, Neradová S, Dlouhý P, Malinová J, Rosina J, Lesná IK. Timing of HPV vaccination as adjuvant treatment of CIN2+ recurrence in women undergoing surgical excision: a meta-analysis and meta-regression. Sex Transm Infect. 2023;99(8):561–6. doi:10.1136/sextrans-2023-055793.
   PubMed Web of Science ®Google Scholar
• Capra G, Giovannelli L, Matranga D, Bellavia C, Guarneri MF, Fasciana T, Scaduto G, Firenze A, Vassiliadis A, Perino A. Potential impact of a nonavalent HPV vaccine on HPV related low-and high-grade cervical intraepithelial lesions: a referral hospital-based study in Sicily. Hum Vaccines Immunother. 2017;13(8):1839–43. doi:10.1080/21645515.2017.1319026.
   PubMed Web of Science ®Google Scholar
• Bosco L, Serra N, Fasciana T, Pistoia D, Vella M, Di Gregorio L, Schillaci R, Perino A, Calagna G, Firenze A, et al. Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations. Sci Rep. 2021;11(1):4096. doi:10.1038/s41598-021-83639-6.
   PubMed Web of Science ®Google Scholar
• Del Pino M, Martí C, Torras I, Henere C, Munmany M, Marimon L, Saco A, Torné A, Ordi J. HPV vaccination as adjuvant to conization in women with cervical intraepithelial neoplasia: a study under real-life conditions. NATO Adv Sci Inst Se. 2020;8(2):245. doi:10.3390/vaccines8020245.
   Google Scholar
• Casajuana-Pérez A, Ramírez-Mena M, Ruipérez-Pacheco E, Gil-Prados I, García-Santos J, Bellón-Del Amo M, Hernández-Aguado JJ, De La Fuente-Valero J, Zapardiel I, Coronado-Martín PJ. Effectiveness of prophylactic human papillomavirus vaccine in the prevention of recurrence in women conized for HSIL/CIN 2–3: the VENUS study. NATO Adv Sci Inst Se. 2022;10(2):288. doi:10.3390/vaccines10020288.
   Google Scholar
• Henere C, Torné A, Llupià A, Aldea M, Martí C, Glickman A, Saco A, Marimon L, Manzotti C, Rakislova N, et al. HPV vaccination in women with cervical intraepithelial neoplasia undergoing excisional treatment: insights into unsolved questions. NATO Adv Sci Inst Se. 2022;10(6):887. doi:10.3390/vaccines10060887.
   Google Scholar
• Paradkar PH, Joshi JV, Mertia PN, Agashe SV, Vaidya RA. Role of cytokines in genesis, progression and prognosis of cervical cancer. Asian Pac J Cancer Prev. 2014;15(9):3851–64. doi:10.7314/APJCP.2014.15.9.3851.
   PubMedGoogle Scholar
• Saftlas AF, Spracklen CN, Ryckman KK, Stockdale CK, Penrose K, Ault K, Rubenstein LM, Pinto LA. Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions. J Reprod Immunol. 2015;109:74–83. doi:10.1016/j.jri.2015.01.002.
   PubMed Web of Science ®Google Scholar
• Zhuang C-L, Lin Z-J, Bi Z-F, Qiu L-X, Hu F-F, Liu X-H, Lin B-Z, Su Y-Y, Pan H-R, Zhang T-Y, et al. Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response. Emerging Microbes Infect. 2021;10(1):365–75. doi:10.1080/22221751.2021.1891002.
   PubMed Web of Science ®Google Scholar
• Abdulaziz AMA, You X, Liu L, Sun Y, Zhang J, Sun S, Li X, Sun W, Dong Y, Liu H, et al. Management of high-grade squamous intraepithelial lesion patients with positive margin after LEEP conization: a retrospective study. Medicine (Baltimore). 2021;100(20):e26030. doi:10.1097/MD.0000000000026030.
   PubMed Web of Science ®Google Scholar
• Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13(5):31. doi:10.4103/sja.SJA_543_18.
   Google Scholar
• Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat- Simul Comput. 2009;38(6):1228–34. doi:10.1080/03610910902859574.
   Web of Science ®Google Scholar
• Kang WD, Choi HS, Kim SM. Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)? Gynecol Oncol. 2013;130(2):264–8. doi:10.1016/j.ygyno.2013.04.050.
   PubMed Web of Science ®Google Scholar
• Grzes B, Heimrath J, Ciszek M. Minimally invasive surgery with the complementing immunotherapy in the treatment of intraepithelial neoplasia of cervix in women of child-bearing age. Onkol Pol. 2011;14:125–30.
   Google Scholar
• Ghelardi A, Parazzini F, Martella F, Pieralli A, Bay P, Tonetti A, Svelato A, Bertacca G, Lombardi S, Joura EA. SPERANZA project: HPV vaccination after treatment for CIN2+. Gynecol Oncol. 2018;151(2):229–34. doi:10.1016/j.ygyno.2018.08.033.
   PubMed Web of Science ®Google Scholar
• Petrillo M, Dessole M, Tinacci E, Saderi L, Muresu N, Capobianco G, Cossu A, Dessole S, Sotgiu G, Piana A. Efficacy of HPV vaccination in women receiving LEEP for cervical dysplasia: a single institution’s experience. NATO Adv Sci Inst Se. 2020;8(1):45. doi:10.3390/vaccines8010045.
   Google Scholar
• Chen M, Li C, Cui Q, Zhou C, Chen P, Yao S. The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: a prospective observational study in China. Eur J Obstet Gyn R B. 2023;286:10–15. doi:10.1016/j.ejogrb.2023.04.014.
   PubMed Web of Science ®Google Scholar
• Pieralli A, Bianchi C, Auzzi N, Fallani MG, Bussani C, Fambrini M, Cariti G, Scarselli G, Petraglia F, Ghelardi A. Indication of prophylactic vaccines as a tool for secondary prevention in HPV-linked disease. Arch Gynecol Obstet. 2018;298(6):1205–10. doi:10.1007/s00404-018-4926-y.
   PubMed Web of Science ®Google Scholar
• Calagna G, Maranto M, Paola C, Capra G, Perino A, Chiantera V, Cucinella G. ‘Secondary prevention’ against female HPV infection: literature review of the role of carrageenan. Expert Rev Anti Infect Ther. 2020;18(9):865–74. doi:10.1080/14787210.2020.1770082.
   PubMed Web of Science ®Google Scholar